Clinical Pharmacokinetics of Cyclophosphamide
Top Cited Papers
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 44 (11) , 1135-1164
- https://doi.org/10.2165/00003088-200544110-00003
Abstract
Cyclophosphamide is an extensively used anticancer and immunosuppressive agent. It is a prodrug undergoing a complicated process of metabolic activation and inactivation. Technical difficulties in...Keywords
This publication has 184 references indexed in Scilit:
- Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsAnnals of Oncology, 2002
- The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human tumour xenograftsEuropean Journal Of Cancer, 1998
- Cyclophosphamide ToxicityDrugs, 1991
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1991
- Cytosolic aldehyde dehydrogenase (ALDH1) variants found in alcohol flushersAnnals of Human Genetics, 1989
- Cyclophosphamide (Cytoxan)Journal of the American Academy of Dermatology, 1984
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979
- Denaturation of cytochrome P-450 by cyclophosphamide metabolitesBiochemical and Biophysical Research Communications, 1978
- Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metaboliteJournal of Mass Spectrometry, 1975
- Studies on Cyclophosphamide Metabolites and Their Related Compounds. ICHEMICAL & PHARMACEUTICAL BULLETIN, 1972